Neuraminidases 3 and 4 regulate neuronal function by catabolizing brain gangliosides

Neuraminidases 3 and 4 regulate neuronal function by catabolizing brain gangliosides

Sialylated glycolipids, gangliosides play an essential role in the central nervous system regulating recognition and signaling in neurons. Metabolic blocks in processing and catabolism of gangliosides result in development of severe neurological disorders, gangliosidoses manifesting with neurodegene...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Pan, X, De Britto Pará De Aragão, C, Velasco-Martin, J, Priestman, D, Wu, H, Takahashi, K, Yamaguchi, K, Sturiale, L, Garozzo, D, Platt, F, Lamarche-Vane, N, Morales, C, Miyagi, T, Pshezhetsky, A
Natura:	Journal article
Pubblicazione:	Federation of American Society of Experimental Biology (FASEB) 2017

Documenti analoghi

Combined deficiencies of endosomal ganglioside neuraminidases 3 and 4 in mice cause lysosomal GM3 gangliosidosis
di: Pshezhetsky, A, et al.
Pubblicazione: (2017)

Combined deficiencies of endosomal ganglioside neuraminidases 3 and 4 in mice cause lysosomal GM3 gangliosidosis
di: Pshezhetsky, A, et al.
Pubblicazione: (2017)

Altered expression of ganglioside metabolizing enzymes results in GM3 ganglioside accumulation in cerebellar cells of a mouse model of juvenile neuronal ceroid lipofuscinosis
di: Somogyi, A, et al.
Pubblicazione: (2018)

An iPSC model of hereditary sensory neuropathy-1 reveals L-serine-responsive deficits in neuronal ganglioside composition and axoglial interactions
di: Clark, A, et al.
Pubblicazione: (2021)

Severe kidney dysfunction in sialidosis mice reveals an essential role for neuraminidase 1 in reabsorption
di: Ikhui Kho, et al.
Pubblicazione: (2023-10-01)

Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease
di: Huebecker, M, et al.
Pubblicazione: (2019)

Mutations in B4GALNT1 (GM2 synthase) underlie a new disorder of ganglioside biosynthesis
di: Harlalka, G, et al.
Pubblicazione: (2013)

Brain pathology in mucopolysaccharidoses (MPS) patients with neurological forms
di: Viana, GM, et al.
Pubblicazione: (2020)

Glycosphingolipid depletion in PC12 cells using iminosugars protects neuronal membranes from anti-ganglioside antibody mediated injury.
di: Townson, K, et al.
Pubblicazione: (2008)

Brain Pathology in Mucopolysaccharidoses (MPS) Patients with Neurological Forms
di: Viana, GM, et al.
Pubblicazione: (2020)

Ganglioside antibodies and neuropathies.
di: Rinaldi, S, et al.
Pubblicazione: (2008)

Editorial: Pharmacology of gangliosides
di: Hongda Zhuang, et al.
Pubblicazione: (2024-07-01)

TLR9-mediated dendritic cell activation uncovers mammalian ganglioside species with specific ceramide backbones that activate invariant natural killer T cells
di: Paget, C, et al.
Pubblicazione: (2019)

GM1 ganglioside-independent intoxication by Cholera toxin
di: Cervin, J, et al.
Pubblicazione: (2018)

Influenza neuraminidase mutations and resistance to neuraminidase inhibitors
di: Jiapeng Xu, et al.
Pubblicazione: (2024-12-01)

N-butyldeoxygalactonojirimycin reduces postnatal cerebellar ganglioside content in a mouse model of GM1 gangliosidosis
di: Kasperzyk, J, et al.
Pubblicazione: (2004)

Substrate deprivation therapy reduces brain ganglioside content and GM1 in neonatal storage disease mice
di: Kasperzyk, J, et al.
Pubblicazione: (2002)

N -butyldeoxynojirimycin reduces growth and ganglioside content of experimental mouse brain tumours.
di: Ranes, M, et al.
Pubblicazione: (2001)

Neuraminidase B controls neuraminidase A-dependent mucus production and evasion.
di: Alexandria J Hammond, et al.
Pubblicazione: (2021-04-01)

N-butyldeoxygalactonojirimycin reduces brain ganglioside and GM2 content in neonatal Sandhoff disease mice.
di: Baek, R, et al.
Pubblicazione: (2008)

N-butyldeoxygalactonojirimycin reduces brain ganglioside and GM2 content in neonatal sandhoff diseased mice
di: Baek, R, et al.
Pubblicazione: (2004)

Substrate reduction therapy reduces brain ganglioside GM2 in neonatal Sandhoff disease mice
di: Baek, R, et al.
Pubblicazione: (2005)

244 Targeting gangliosides in pediatric cancer
di: Min Huang, et al.
Pubblicazione: (2023-11-01)

N-butyldeoxygalactonojirimycin reduces neonatal brain ganglioside content in a mouse model of GM1 gangliosidosis.
di: Kasperzyk, J, et al.
Pubblicazione: (2004)

Neuraminidase inhibitors for influenza complications.
di: Del Mar, C, et al.
Pubblicazione: (2014)

Dietary Ganglioside Reduces Proinflammatory Signaling in the Intestine
di: John Janez Miklavcic, et al.
Pubblicazione: (2012-01-01)

9-O Acetylated Gangliosides in Health and Disease
di: Luis Vicente Herrera-Marcos, et al.
Pubblicazione: (2023-05-01)

"Substrate reduction reduces gangliosides in postnatal cerebrum-brainstem and cerebellum in GM1 gangliosidosis mice" (vol 46, pg 744, 2004)
di: Kasperzyk, J, et al.
Pubblicazione: (2005)

Are anti-ganglioside antibodies associated with proventricular dilatation disease in birds?
di: Jeann Leal de Araujo, et al.
Pubblicazione: (2017-04-01)

Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children
di: Jefferson, T, et al.
Pubblicazione: (2014)

Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children.
di: Jefferson, T, et al.
Pubblicazione: (2014)

Pharmacokinetic Properties of Anti-Influenza Neuraminidase Inhibitors.
di: Chairat, K, et al.
Pubblicazione: (2012)

Pharmacokinetic properties of anti-influenza neuraminidase inhibitors.
di: Chairat, K, et al.
Pubblicazione: (2013)

Interorgan Metabolism of Ganglioside Is Altered in Type 2 Diabetes
di: Irma Magaly Rivas Serna, et al.
Pubblicazione: (2022-12-01)

Gangliosides and Their Role in Multilineage Differentiation of Mesenchymal Stem Cells
di: Francesca Santilli, et al.
Pubblicazione: (2022-12-01)

The Key Role of GM1 Ganglioside in Parkinson’s Disease
di: Suman Chowdhury, et al.
Pubblicazione: (2022-01-01)

Studying catabolism of protein ADP-Ribosylation
di: Palazzo, L, et al.
Pubblicazione: (2017)

New GM1 Ganglioside Derivatives for Selective Single and Double Labelling of the Natural Glycosphingolipid Skeleton
di: Polyakova, S, et al.
Pubblicazione: (2009)

Altered expression of genes involved in ganglioside biosynthesis in substantia nigra neurons in Parkinson's disease.
di: Jay S Schneider
Pubblicazione: (2018-01-01)

Neuraminidase inhibitors for preventing and treating influenza in children
di: Wang, K, et al.
Pubblicazione: (2012)